For the first time, Medicare will cover GLP-1s for obesity-related weight loss, without any other medical conditions.

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1.

Popular Novo Nordisk and Eli Lilly drugs are included